학술논문
Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim
Document Type
Article
Author
Source
In: Annals of Hematology . (Annals of Hematology, March 2024, 103(3):947-956)
Subject
Language
English
ISSN
14320584
09395555
09395555